• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Advances in Cystic Fibrosis, An Issue of Clinics in Chest Medicine

Advances in Cystic Fibrosis, An Issue of Clinics in Chest Medicine

9780323849616
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
529.15 zł
449.78 zł Save 79.37 zł Tax included
Lowest price within 30 days before promotion: 449.78 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Clinics in Chest Medicine, guest editors Drs. Clemente J. Britto and Jennifer L. Taylor-Cousar bring their considerable expertise to Advances in Cystic Fibrosis. Top experts in the field cover key topics such as genetics of cystic fibrosis (CF):: clinical implications; innate and adaptive immunity in CF; novel applications of biomarkers and personalized medicine to define the spectrum of CF; emerging approaches to understand CF pathogenesis; and more.
Product Details
Elsevier
94181
9780323849616
9780323849616

Data sheet

Publication date
2022
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
178 x 254
Weight (g)
750
  • Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations
    Genetics of Cystic Fibrosis: Clinical Implications
    Update on Innate and Adaptive Immunity in Cystic Fibrosis
    Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis
    Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance Regulators
    The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation
    Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis
    Update on Clinical Outcomes of Highly Effective Modulator Therapy
    Nontuberculous Mycobacterial Infections in Cystic Fibrosis
    Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient
    Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era
    Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis
    Transitions of Care in Cystic Fibrosis
    Endocrine Complications of Cystic Fibrosis
    Management of Mental Health in Cystic Fibrosis
    Family Planning and Reproductive Health in Cystic Fibrosis
    Update on Lung Transplantation for Cystic Fibrosis
Comments (0)